What is Lumicks?
Lumicks is a leading life science tools company specializing in the development of sophisticated equipment for Dynamic Single-Molecule and Cell Avidity analysis. These two areas represent rapidly emerging fields within biology research and immuno-oncology, positioning Lumicks at the forefront of scientific discovery and therapeutic development. The company's technology enables researchers to gain deeper insights into cellular interactions and molecular mechanisms, crucial for advancing our understanding of diseases and developing novel treatments.
How much funding has Lumicks raised?
Lumicks has raised a total of $93M across 1 funding round:
Series D
$93M
Series D (2021): $93M with participation from Irving Investors, Lauxera Capital Partners, Farallon Capital Management LLC, and Pura Vida Investments LLC
Key Investors in Lumicks
Irving Investors
Irving Investors is likely a venture capital or private equity firm focused on providing growth capital to companies in various sectors, including life sciences.
Lauxera Capital Partners
Lauxera Capital Partners is an investment firm that may specialize in supporting innovative companies, potentially within the technology or healthcare sectors.
Farallon Capital Management LLC
Farallon Capital Management LLC is a global investment management firm known for its diverse investment strategies, potentially including significant stakes in growth-stage companies.
What's next for Lumicks?
With substantial enterprise-level backing and a recent strategic investment, Lumicks is poised for accelerated growth and further innovation in the life science tools market. The company's focus on dynamic single-molecule and cell avidity analysis aligns with critical trends in biological research and the burgeoning field of immuno-oncology. This strategic financing is expected to bolster Lumicks' research and development efforts, expand its market reach, and enhance its product offerings, solidifying its position as a key enabler of cutting-edge biological insights and therapeutic advancements.
See full Lumicks company page
